Yashpal Singh Malik Selected Research

COVID-19

9/2023	Neutralising antibodies against SARS-CoV-2 give important information on Covid-19 epidemic evolution in Rabat, Morocco, March 2020-February 2021.
1/2022	A novel structure-based approach for identification of vertebrate susceptibility to SARS-CoV-2: Implications for future surveillance programmes.
1/2022	CRISPR use in diagnosis and therapy for COVID-19.
11/2021	Responses to COVID-19 in South Asian Association for Regional Cooperation (SAARC) countries in 2020, a data analysis during a world of crises.
7/2021	The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment.
1/2021	How artificial intelligence may help the Covid-19 pandemic: Pitfalls and lessons for the future.
12/2020	COVID-19 in the elderly people and advances in vaccination approaches.
12/2020	COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.
12/2020	BCG vaccine: a hope to control COVID-19 pandemic amid crisis.
9/2020	SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yashpal Singh Malik Research Topics

Disease

16	COVID-19 09/2023 - 01/2020
8	Infections 01/2021 - 07/2016
5	Virus Diseases (Viral Diseases) 09/2021 - 12/2013
2	Diarrhea 12/2022 - 01/2017
1	Enteritis 04/2024
1	Tuberculosis (Tuberculoses) 12/2020
1	Lymphopenia (Lymphocytopenia) 09/2020
1	Leukopenia 09/2020
1	Thrombocytopenia (Thrombopenia) 09/2020
1	Coronavirus Infections 01/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Vesicular Stomatitis 01/2018
1	Animal Diseases 12/2017
1	Influenza in Birds (Avian Flu) 12/2016
1	Marek Disease (Marek's Disease) 10/2016
1	Lymphoma (Lymphomas) 10/2016

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 12/2020 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2016
3	AntibodiesIBA 09/2023 - 07/2016
3	Antiviral Agents (Antivirals)IBA 09/2020 - 12/2013
2	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 01/2018
2	InterferonsIBA 01/2021 - 07/2016
2	COVID-19 VaccinesIBA 12/2020 - 12/2020
2	Interleukin-2 (IL2)IBA 09/2019 - 07/2016
1	Immunoglobulin G (IgG)IBA 12/2022
1	ZincIBA 12/2022
1	CopperIBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 12/2022
1	Immunoglobulin A (IgA)IBA 12/2022
1	Guanosine Diphosphate (GDP)IBA 11/2021
1	Disinfectants (Biocides)IBA 07/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	BCG Vaccine FDA Link 12/2020
1	CytokinesIBA 09/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2020
1	ChemokinesIBA 09/2020
1	Interleukin-4 (Interleukin 4)IBA 09/2019
1	Interleukin-1 (Interleukin 1)IBA 09/2019
1	CPG-oligonucleotideIBA 09/2019
1	Neutralizing AntibodiesIBA 01/2018
1	Synthetic DrugsIBA 12/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Neuraminidase (Sialidase)IBA 12/2016
1	EnzymesIBA 10/2016
1	Tissue ExtractsIBA 10/2016
1	ImmunosorbentsIBA 10/2016
1	Oncogene Proteins (Oncogene Protein)IBA 10/2016
1	AntigensIBA 10/2016
1	Interleukin-12 (IL 12)IBA 07/2016
1	InterleukinsIBA 07/2016
1	Peptides (Polypeptides)IBA 12/2013
1	Dendrimers (Dendrons)IBA 12/2013
1	LigandsIBA 12/2013

Therapy/Procedure

7	Therapeutics 12/2022 - 01/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2020